EMEA (Europe, Middle East and Africa) Embolization Particle Market 2017 Forecast to 2022

Publisher Name :
Date: 11-Apr-2018
No. of pages: 118

Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.

Scope of the Report:

This report focuses on the Embolization Particle in EMEA market, covering Europe, Middle East and Africa, This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

- Sirtex Medical

- Merit Medical

- Cook Medical

- BTG Medical

- Boston Scientific Corporation

- Terumo Corporation

- HENGRUI Medical

- INterface BIOmaterials B.V.

- Alicon

Market Segment by Regions, regional analysis covers

- Europe (Germany, France, UK, Russia, Italy and Turkey)

- Middle East (Saudi Arabia, Israel, UAE and Iran)

- Africa (South Africa, Nigeria, Egypt and Algeria)

Market Segment by Type, covers

- Microspheres

- Particles (e.g. PVA Particles, Gelfoam Particles)

- Drug-eluting Beads (DEBs)

- Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)

Market Segment by Applications, can be divided into

- Uterine Fibroid Embolization

- Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)

- Liver Tumor Embolization

- Trauma Embolization

- Other

There are 13 Chapters to deeply display the EMEA Embolization Particle market.

Chapter 1, to describe Embolization Particle Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Embolization Particle, with sales, revenue, and price of Embolization Particle, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the EMEA market by regions, with sales, revenue and market share of Embolization Particle, for each region, from 2012 to 2017;

Chapter 5, 6, 7, to analyze the market by regions, manufacturers, type and application, with sales, revenue and market share by key countries in these regions;

Chapter 8 and 9, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 10, Embolization Particle market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 11, 12 and 13, to describe Embolization Particle research findings and conclusion, sales channel, distributors, traders, dealers, appendix and data source

EMEA (Europe, Middle East and Africa) Embolization Particle Market 2017 Forecast to 2022

Table of Contents

1 Market Overview
1.1 Embolization Particle Introduction
1.2 Market Analysis by Type
1.2.1 Microspheres
1.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
1.2.3 Drug-eluting Beads (DEBs)
1.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
1.3 Market Analysis by Applications
1.3.1 Uterine Fibroid Embolization
1.3.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
1.3.3 Liver Tumor Embolization
1.3.4 Trauma Embolization
1.3.5 Other
1.4 Market Analysis by Regions
1.4.1 Europe (Germany, France, UK, Italy, Russia and Turkey)
1.4.1.1 Germany Market States and Outlook (2012-2022)
1.4.1.2 France Market States and Outlook (2012-2022)
1.4.1.3 UK Market States and Outlook (2012-2022)
1.4.1.4 Italy Market States and Outlook (2012-2022)
1.4.1.5 Russia Market States and Outlook (2012-2022)
1.4.1.6 Turkey Market States and Outlook (2012-2022)
1.4.2 Middle East (Saudi Arabia, Israel, UAE and Iran)
1.4.2.1 Saudi Arabia Market States and Outlook (2012-2022)
1.4.2.2 UAE Market States and Outlook (2012-2022)
1.4.2.3 Israel Market States and Outlook (2012-2022)
1.4.2.4 Iran Market States and Outlook (2012-2022)
1.4.3 Africa (South Africa, Nigeria, Egypt and Algeria)
1.4.3.1 South Africa Market States and Outlook (2012-2022)
1.4.3.2 Nigeria Market States and Outlook (2012-2022)
1.4.3.3 Egypt Market States and Outlook (2012-2022)
1.4.3.4 Algeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Sirtex Medical
2.1.1 Business Overview
2.1.2 Embolization Particle Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Sirtex Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Merit Medical
2.2.1 Business Overview
2.2.2 Embolization Particle Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Merit Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Cook Medical
2.3.1 Business Overview
2.3.2 Embolization Particle Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Cook Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 BTG Medical
2.4.1 Business Overview
2.4.2 Embolization Particle Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 BTG Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Boston Scientific Corporation
2.5.1 Business Overview
2.5.2 Embolization Particle Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Boston Scientific Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Terumo Corporation
2.6.1 Business Overview
2.6.2 Embolization Particle Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Terumo Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 HENGRUI Medical
2.7.1 Business Overview
2.7.2 Embolization Particle Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 HENGRUI Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 INterface BIOmaterials B.V.
2.8.1 Business Overview
2.8.2 Embolization Particle Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Alicon
2.9.1 Business Overview
2.9.2 Embolization Particle Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Alicon Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 EMEA Embolization Particle Market Competition, by Manufacturer
3.1 EMEA Embolization Particle Sales and Market Share by Manufacturer
3.2 EMEA Embolization Particle Revenue and Market Share by Manufacturer
3.3 EMEA Embolization Particle Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
3.4.1 Top 3 Embolization Particle Manufacturer Market Share
3.4.2 Top 5 Embolization Particle Manufacturer Market Share
3.5 Market Competition Trend
4 EMEA Embolization Particle Market Analysis by Regions
4.1 EMEA Embolization Particle Sales, Revenue and Market Share by Regions
4.1.1 EMEA Embolization Particle Sales by Regions (2012-2017)
4.1.2 EMEA Embolization Particle Revenue by Regions (2012-2017)
4.2 Europe Embolization Particle Sales and Growth (2012-2017)
4.3 Middle East Embolization Particle Sales and Growth (2012-2017)
4.4 Africa Embolization Particle Sales and Growth (2012-2017)
5 Europe Embolization Particle by Countries, Type, Application and Manufacturers
5.1 Europe Embolization Particle Sales, Revenue and Market Share by Countries
5.1.1 Europe Embolization Particle Sales by Countries (2012-2017)
5.1.2 Europe Embolization Particle Revenue by Countries (2012-2017)
5.1.3 Germany Embolization Particle Sales and Growth (2012-2017)
5.1.4 France Embolization Particle Sales and Growth (2012-2017)
5.1.5 UK Embolization Particle Sales and Growth (2012-2017)
5.1.6 Russia Embolization Particle Sales and Growth (2012-2017)
5.1.7 Italy Embolization Particle Sales and Growth (2012-2017)
5.1.8 Turkey Embolization Particle Sales and Growth (2012-2017)
5.2 Europe Embolization Particle Sales and Revenue (value) by Manufacturers (2016-2017)
5.2.1 Europe Embolization Particle Sales by Manufacturers (2016-2017)
5.2.2 Europe Embolization Particle Revenue by Manufacturers (2016-2017)
5.3 Europe Embolization Particle Sales by Type (2012-2017)
5.4 Europe Embolization Particle Sales by Application (2012-2017)
6 Middle East Embolization Particle by Countries, Type, Application and Manufacturers
6.1 Middle East Embolization Particle Sales, Revenue and Market Share by Countries
6.1.1 Middle East Embolization Particle Sales by Countries (2012-2017)
6.1.2 Middle East Embolization Particle Revenue by Countries (2012-2017)
6.1.3 Saudi Arabia Embolization Particle Sales and Growth (2012-2017)
6.1.4 Israel Embolization Particle Sales and Growth (2012-2017)
6.1.5 UAE Embolization Particle Sales and Growth (2012-2017)
6.1.6 Iran Embolization Particle Sales and Growth (2012-2017)
6.2 Middle East Embolization Particle Sales and Revenue (value) by Manufacturers (2016-2017)
6.2.1 Middle East Embolization Particle Sales by Manufacturers (2016-2017)
6.2.2 Middle East Embolization Particle Revenue by Manufacturers (2016-2017)
6.3 Middle East Embolization Particle Sales by Type (2012-2017)
6.4 Middle East Embolization Particle Sales by Application (2012-2017)
7 Africa Embolization Particle by Countries, Type, Application and Manufacturers
7.1 Africa Embolization Particle Sales, Revenue and Market Share by Countries
7.1.1 Africa Embolization Particle Sales by Countries (2012-2017)
7.1.2 Africa Embolization Particle Revenue by Countries (2012-2017)
7.1.3 South Africa Embolization Particle Sales and Growth (2012-2017)
7.1.4 Nigeria Embolization Particle Sales and Growth (2012-2017)
7.1.5 Egypt Embolization Particle Sales and Growth (2012-2017)
7.1.6 Algeria Embolization Particle Sales and Growth (2012-2017)
7.2 Middle East Embolization Particle Sales and Revenue (value) by Manufacturers (2016-2017)
7.2.1 Middle East Embolization Particle Sales by Manufacturers (2016-2017)
7.2.2 Middle East Embolization Particle Revenue by Manufacturers (2016-2017)
7.3 Middle East Embolization Particle Sales by Type (2012-2017)
7.4 Middle East Embolization Particle Sales by Application (2012-2017)
8 EMEA Embolization Particle Market Segment by Type
8.1 EMEA Embolization Particle Sales, Revenue and Market Share by Type (2012-2017)
8.1.1 EMEA Embolization Particle Sales and Market Share by Type (2012-2017)
8.1.2 EMEA Embolization Particle Revenue and Market Share by Type (2012-2017)
8.2 Microspheres Sales Growth and Price
10.2.1 EMEA Microspheres Sales Growth (2012-2017)
10.2.2 EMEA Microspheres Price (2012-2017)
8.3 Particles (e.g. PVA Particles, Gelfoam Particles) Sales Growth and Price
10.3.1 EMEA Particles (e.g. PVA Particles, Gelfoam Particles) Sales Growth (2012-2017)
10.3.2 EMEA Particles (e.g. PVA Particles, Gelfoam Particles) Price (2012-2017)
8.4 Drug-eluting Beads (DEBs) Sales Growth and Price
10.4.1 EMEA Drug-eluting Beads (DEBs) Sales Growth (2012-2017)
10.4.2 EMEA Drug-eluting Beads (DEBs) Price (2012-2017)
8.5 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Sales Growth and Price
10.5.1 EMEA Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Sales Growth (2012-2017)
10.5.2 EMEA Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Price (2012-2017)
9 EMEA Embolization Particle Market Segment by Application
9.1 EMEA Embolization Particle Sales Market Share by Application (2012-2017)
9.2 Uterine Fibroid Embolization Sales Growth (2012-2017)
9.3 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Sales Growth (2012-2017)
9.4 Liver Tumor Embolization Sales Growth (2012-2017)
9.5 Trauma Embolization Sales Growth (2012-2017)
9.6 Other Sales Growth (2012-2017)
10 EMEA Embolization Particle Market Forecast (2017-2022)
10.1 EMEA Embolization Particle Sales, Revenue and Growth Rate (2017-2022)
10.2 Embolization Particle Market Forecast by Regions (2017-2022)
10.2.1 Europe Embolization Particle Market Forecast by Regions (2017-2022)
10.2.1.1 Germany Embolization Particle Sales Forecast 2017-2022
10.2.1.2 France Embolization Particle Sales Forecast 2017-2022
10.2.1.3 UK Embolization Particle Sales Forecast 2017-2022
10.2.1.4 Russia Embolization Particle Sales Forecast 2017-2022
10.2.1.5 Italy Embolization Particle Sales Forecast 2017-2022
10.2.1.6 Turkey Embolization Particle Sales Forecast 2017-2022
10.2.2 Middle East Market Forecast by Regions (2017-2022)
10.2.2.1 Saudi Arabia Embolization Particle Sales Forecast 2017-2022
10.2.2.2 Israel Embolization Particle Sales Forecast 2017-2022
10.2.2.3 UAE Embolization Particle Sales Forecast 2017-2022
10.2.2.4 Iran Embolization Particle Sales Forecast 2017-2022
10.2.3 Africa Market Forecast by Regions (2017-2022)
10.2.3.1 South Africa Embolization Particle Sales Forecast 2017-2022
10.2.3.2 Nigeria Embolization Particle Sales Forecast 2017-2022
10.2.3.3 Egypt Embolization Particle Sales Forecast 2017-2022
10.2.3.4 Algeria Embolization Particle Sales Forecast 2017-2022
10.3 Embolization Particle Market Forecast by Type (2017-2022)
10.4 Embolization Particle Market Forecast by Application (2017-2022)
11 Sales Channel, Distributors, Traders and Dealers
11.1 Sales Channel
11.1.1 Direct Marketing
11.1.2 Indirect Marketing
11.1.3 Marketing Channel Future Trend
11.2 Distributors, Traders and Dealers
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology
13.2 Analyst Introduction
13.3 Data Source

List of Tables and Figures

Figure Embolization Particle Picture
Table Product Specifications of Embolization Particle
Figure EMEA Sales Market Share of Embolization Particle by Types in 2016
Table Embolization Particle Types for Major Manufacturers
Figure Microspheres Picture
Figure Particles (e.g. PVA Particles, Gelfoam Particles) Picture
Figure Drug-eluting Beads (DEBs) Picture
Figure Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Picture
Table Embolization Particle Sales Market Share by Applications in 2016
Figure Uterine Fibroid Embolization Picture
Figure Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Picture
Figure Liver Tumor Embolization Picture
Figure Trauma Embolization Picture
Figure Other Picture
Figure Germany Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure France Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure UK Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Turkey Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure UAE Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Israel Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Iran Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Figure Algeria Embolization Particle Revenue (Value) and Growth Rate (2012-2022)
Table Sirtex Medical Basic Information, Manufacturing Base and Competitors
Table Sirtex Medical Embolization Particle Type and Applications
Table Sirtex Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merit Medical Basic Information, Manufacturing Base and Competitors
Table Merit Medical Embolization Particle Type and Applications
Table Merit Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Cook Medical Basic Information, Manufacturing Base and Competitors
Table Cook Medical Embolization Particle Type and Applications
Table Cook Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table BTG Medical Basic Information, Manufacturing Base and Competitors
Table BTG Medical Embolization Particle Type and Applications
Table BTG Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors
Table Boston Scientific Corporation Embolization Particle Type and Applications
Table Boston Scientific Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Terumo Corporation Basic Information, Manufacturing Base and Competitors
Table Terumo Corporation Embolization Particle Type and Applications
Table Terumo Corporation Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table HENGRUI Medical Basic Information, Manufacturing Base and Competitors
Table HENGRUI Medical Embolization Particle Type and Applications
Table HENGRUI Medical Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table INterface BIOmaterials B.V. Basic Information, Manufacturing Base and Competitors
Table INterface BIOmaterials B.V. Embolization Particle Type and Applications
Table INterface BIOmaterials B.V. Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Alicon Basic Information, Manufacturing Base and Competitors
Table Alicon Embolization Particle Type and Applications
Table Alicon Embolization Particle Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table EMEA Embolization Particle Sales by Manufacturer (2016-2017)
Figure EMEA Embolization Particle Sales Market Share by Manufacturer in 2016
Figure EMEA Embolization Particle Sales Market Share by Manufacturer in 2017
Table EMEA Embolization Particle Revenue by Manufacturer (2016-2017)
Figure EMEA Embolization Particle Revenue Market Share by Manufacturer in 2016
Figure EMEA Embolization Particle Revenue Market Share by Manufacturer in 2017
Table EMEA Embolization Particle Price by Manufacturer (2016-2017)
Figure EMEA Embolization Particle Sales and Growth (2012-2017)
Figure EMEA Embolization Particle Revenue and Growth (2012-2017)
Table EMEA Embolization Particle Sales by Regions (2012-2017)
Table EMEA Embolization Particle Sales Market Share by Regions (2012-2017)
Figure EMEA Embolization Particle Sales Market Share by Regions in 2012
Figure EMEA Embolization Particle Sales Market Share by Regions in 2016
Table EMEA Embolization Particle Revenue by Regions (2012-2017)
Table EMEA Embolization Particle Revenue Market Share by Regions (2012-2017)
Figure EMEA Embolization Particle Revenue Market Share by Regions in 2012
Figure EMEA Embolization Particle Revenue Market Share by Regions in 2016
Figure Europe Embolization Particle Sales and Growth (2012-2017)
Figure Middle East Embolization Particle Sales and Growth (2012-2017)
Figure Africa Embolization Particle Sales and Growth (2012-2017)
Figure Europe Embolization Particle Revenue and Growth (2012-2017)
Table Europe Embolization Particle Sales by Countries (2012-2017)
Table Europe Embolization Particle Sales Market Share by Countries (2012-2017)
Figure Europe Embolization Particle Sales Market Share by Countries in 2012
Figure Europe Embolization Particle Sales Market Share by Countries in 2016
Table Europe Embolization Particle Revenue by Countries (2012-2017)
Table Europe Embolization Particle Revenue Market Share by Countries (2012-2017)
Figure Europe Embolization Particle Revenue Market Share by Countries in 2012
Figure Europe Embolization Particle Revenue Market Share by Countries in 2016
Figure Germany Embolization Particle Sales and Growth (2012-2017)
Figure France Embolization Particle Sales and Growth (2012-2017)
Figure UK Embolization Particle Sales and Growth (2012-2017)
Figure Russia Embolization Particle Sales and Growth (2012-2017)
Figure Italy Embolization Particle Sales and Growth (2012-2017)
Figure Turkey Embolization Particle Sales and Growth (2012-2017)
Table Europe Embolization Particle Sales by Manufacturer (2016-2017)
Figure Europe Embolization Particle Sales Market Share by Manufacturer in 2016
Figure Europe Embolization Particle Sales Market Share by Manufacturer in 2017
Table Europe Embolization Particle Revenue by Manufacturer (2016-2017)
Figure Europe Embolization Particle Revenue Market Share by Manufacturer in 2016
Figure Europe Embolization Particle Revenue Market Share by Manufacturer in 2017
Table Europe Embolization Particle Sales by Type (2012-2017)
Table Europe Embolization Particle Sales Share by Type (2012-2017)
Table Europe Embolization Particle Sales by Application (2012-2017)
Table Europe Embolization Particle Sales Share by Application (2012-2017)
Figure Middle East Embolization Particle Revenue and Growth (2012-2017)
Table Middle East Embolization Particle Sales by Countries (2012-2017)
Table Middle East Embolization Particle Sales Market Share by Countries (2012-2017)
Figure Middle East Embolization Particle Sales Market Share by Countries in 2012
Figure Middle East Embolization Particle Sales Market Share by Countries in 2016
Table Middle East Embolization Particle Revenue by Countries (2012-2017)
Table Middle East Embolization Particle Revenue Market Share by Countries (2012-2017)
Figure Middle East Embolization Particle Revenue Market Share by Countries in 2012
Figure Middle East Embolization Particle Revenue Market Share by Countries in 2016
Figure Saudi Arabia Embolization Particle Sales and Growth (2012-2017)
Figure Israel Embolization Particle Sales and Growth (2012-2017)
Figure UAE Embolization Particle Sales and Growth (2012-2017)
Figure Iran Embolization Particle Sales and Growth (2012-2017)
Table Middle East Embolization Particle Sales by Manufacturer (2016-2017)
Figure Middle East Embolization Particle Sales Market Share by Manufacturer in 2016
Figure Middle East Embolization Particle Sales Market Share by Manufacturer in 2017
Table Middle East Embolization Particle Revenue by Manufacturer (2016-2017)
Figure Middle East Embolization Particle Revenue Market Share by Manufacturer in 2016
Figure Middle East Embolization Particle Revenue Market Share by Manufacturer in 2017
Table Middle East Embolization Particle Sales by Type (2012-2017)
Table Middle East Embolization Particle Sales Share by Type (2012-2017)
Table Middle East Embolization Particle Sales by Application (2012-2017)
Table Middle East Embolization Particle Sales Share by Application (2012-2017)
Figure Africa Embolization Particle Revenue and Growth (2012-2017)
Table Africa Embolization Particle Sales by Countries (2012-2017)
Table Africa Embolization Particle Sales Market Share by Countries (2012-2017)
Figure Africa Embolization Particle Sales Market Share by Countries in 2012
Figure Africa Embolization Particle Sales Market Share by Countries in 2016
Table Africa Embolization Particle Revenue by Countries (2012-2017)
Table Africa Embolization Particle Revenue Market Share by Countries (2012-2017)
Figure Africa Embolization Particle Revenue Market Share by Countries in 2012
Figure Africa Embolization Particle Revenue Market Share by Countries in 2016
Figure South Africa Embolization Particle Sales and Growth (2012-2017)
Figure Nigeria Embolization Particle Sales and Growth (2012-2017)
Figure Egypt Embolization Particle Sales and Growth (2012-2017)
Figure Algeria Embolization Particle Sales and Growth (2012-2017)
Table Middle East Embolization Particle Sales by Manufacturer (2016-2017)
Figure Middle East Embolization Particle Sales Market Share by Manufacturer in 2016
Figure Middle East Embolization Particle Sales Market Share by Manufacturer in 2017
Table Middle East Embolization Particle Revenue by Manufacturer (2016-2017)
Figure Middle East Embolization Particle Revenue Market Share by Manufacturer in 2016
Figure Middle East Embolization Particle Revenue Market Share by Manufacturer in 2017
Table Middle East Embolization Particle Sales by Type (2012-2017)
Table Middle East Embolization Particle Sales Share by Type (2012-2017)
Table Middle East Embolization Particle Sales by Application (2012-2017)
Table Middle East Embolization Particle Sales Share by Application (2012-2017)
Table EMEA Embolization Particle Sales by Type (2012-2017)
Table EMEA Embolization Particle Sales Share by Type (2012-2017)
Table EMEA Embolization Particle Revenue by Type (2012-2017)
Table EMEA Embolization Particle Revenue Share by Type (2012-2017)
Figure EMEA Microspheres Sales Growth (2012-2017)
Figure EMEA Microspheres Price (2012-2017)
Figure EMEA Particles (e.g. PVA Particles, Gelfoam Particles) Sales Growth (2012-2017)
Figure EMEA Particles (e.g. PVA Particles, Gelfoam Particles) Price (2012-2017)
Figure EMEA Drug-eluting Beads (DEBs) Sales Growth (2012-2017)
Figure EMEA Drug-eluting Beads (DEBs) Price (2012-2017)
Figure EMEA Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Sales Growth (2012-2017)
Figure EMEA Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere) Price (2012-2017)
Table EMEA Embolization Particle Sales by Application (2012-2017)
Table EMEA Embolization Particle Sales Share by Application (2012-2017)
Figure EMEA Uterine Fibroid Embolization Sales Growth (2012-2017)
Figure EMEA Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH) Sales Growth (2012-2017)
Figure EMEA Liver Tumor Embolization Sales Growth (2012-2017)
Figure EMEA Trauma Embolization Sales Growth (2012-2017)
Figure EMEA Other Sales Growth (2012-2017)
Figure EMEA Embolization Particle Sales, Revenue and Growth Rate (2017-2022)
Table EMEA Embolization Particle Sales Forecast by Regions (2017-2022)
Table EMEA Embolization Particle Market Share Forecast by Regions (2017-2022)
Table Europe Embolization Particle Sales Forecast by Regions (2017-2022)
Figure Germany Embolization Particle Sales Forecast 2017-2022
Figure France Embolization Particle Sales Forecast 2017-2022
Figure UK Embolization Particle Sales Forecast 2017-2022
Figure Russia Embolization Particle Sales Forecast 2017-2022
Figure Italy Embolization Particle Sales Forecast 2017-2022
Figure Turkey Embolization Particle Sales Forecast 2017-2022
Table Middle East Sales Forecast by Regions (2017-2022)
Figure Saudi Arabia Embolization Particle Sales Forecast 2017-2022
Figure Israel Embolization Particle Sales Forecast 2017-2022
Figure UAE Embolization Particle Sales Forecast 2017-2022
Figure Iran Embolization Particle Sales Forecast 2017-2022
Table Africa Sales Forecast by Regions (2017-2022)
Figure South Africa Embolization Particle Sales Forecast 2017-2022
Figure Nigeria Embolization Particle Sales Forecast 2017-2022
Figure Egypt Embolization Particle Sales Forecast 2017-2022
Figure Algeria Embolization Particle Sales Forecast 2017-2022
Table EMEA Embolization Particle Sales Forecast by Type (2017-2022)
Table EMEA Embolization Particle Market Share Forecast by Type (2017-2022)
Table EMEA Embolization Particle Sales Forecast by Application (2017-2022)
Table EMEA Embolization Particle Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Liquid Chromatography Detectors Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 109
    Liquid Chromatography Detectors is a device used in liquid chromatography (LC) to detect components of the mixture being eluted off the chromatography column. A broad range of detectors is available to meet different sample requirements. Specific detectors respond to a particular compound only and the response is independent of mobile phase composition. On the other hand the response of bulk property detectors is dependent on collective changes in composition of sample and mobile phase. ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) IV Bags Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 103
    This report studies the IV Bag market including flex plastics bag, semi-rigid IV Bags, glass bottles. Scope of the Report: This report focuses on the IV Bags in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application. Market Segment by Manufacturers, this report covers - Baxter - SSY Group - ......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Fractional Flow Reserve Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Fractional flow reserve (FFR) is a technique used in coronary catheterization to measure pressure differences across a coronary artery stenosis (narrowing, usually due to atherosclerosis) to determine the likelihood that the stenosis impedes oxygen delivery to the heart muscle (myocardial ischemia). Scope of the Report: This report focuses on the Fractional Flow Reserve in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle Eas......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) ICAD (Intracranial Atherosclerotic Disease) Pathology Market 2018 Forecast to 2023
    Published: 15-May-2018        Price: US 4880 Onwards        Pages: 107
    Intracranial atherosclerotic disease is the progressive narrowing of the cerebral arteries within the skull (intracranial). The arteries that supply oxygen-enriched blood to the brain are the carotid arteries and the vertebral arteries. The circle of Willis is the area at the base of the brain that joins these arteries. Scope of the Report: This report focuses on the ICAD (Intracranial Atherosclerotic Disease) Pathology in Global market, especially in North America,......
  • North America and Europe APAC Hydrocolloid Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    A hydrocolloid dressing is an opaque or transparent dressing for wounds. A hydrocolloid dressing is biodegradeable, non-breathable, and adheres to the skin, so no separate taping is needed. Scope of the Report: This report focuses on the APAC Hydrocolloid in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and appl......
  • North America and Europe APAC Silver Dressing Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 103
    Silver dressings are a relatively new family of advanced wound care dressings for the treatment of infected wounds. A silver dressing is a wound dressing impregnated with ionic silver. The ionic silver is responsible for the anti-microbial activity against infection caused by bacteria. Scope of the Report: This report focuses on the APAC Silver Dressing in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy an......
  • North America and Europe Breast Lesion Localization Methods Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 109
    This report studies the Breast Lesion Localization Methods market, including wire localization biopsy, radioisotope localization, magnetic tracer and other products. Scope of the Report: This report focuses on the Breast Lesion Localization Methods in North America and Europe market, especially in United States, United Kingdom, Canada, Germany, France, Italy and Spain. This report categorizes the market based on manufacturers, countries/Regions, type and application......
  • North America and Europe Casting and Splinting Products Market by Manufacturers, Regions, Type and Application, Forecast to 2023
    Published: 04-May-2018        Price: US 4480 Onwards        Pages: 105
    An orthopedic cast, or simply cast, is a shell, frequently made from plaster or fiberglass, encasing a limb (or, in some cases, large portions of the body) to stabilize and hold anatomical structures, most often a broken bone (or bones), in place until healing is confirmed. It is similar in function to a splint. Scope of the Report: This report focuses on the Casting and Splinting Products in North America and Europe market, especially in United States, United Kingd......
  • Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Oncolytic Virus Therapy Market 2018 Forecast to 2023
    Published: 27-Apr-2018        Price: US 4880 Onwards        Pages: 108
    Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs